Tyra Biosciences, Inc.

Ownership Transactions Reported by 27 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	2	-225K	100%	$17.04	-$3.84M
Net	-2	-225K	-100%		-$3.84M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Ra Capital Management, L.P.	Director, 10%+ Owner	$130M			May 29, 2024
Boxer Capital, LLC	Other*	$94.2M			Feb 6, 2024
Alta Partners NextGen Fund II Management, LLC	10%+ Owner	$26.8M			Sep 17, 2021
Todd Harris	President and CEO, Director	$9.9M	-$1.66M	-14.3%	Aug 14, 2024
Daniel Bensen	Chief Operating Officer	$8.56M	-$2.18M	-20.3%	Aug 14, 2024
Cormorant Asset Management, LP	Former 10% Owner	$7.04M			Sep 17, 2021
Canaan XI L.P.	10%+ Owner	$3.11M			Sep 17, 2021
Robert L. Hudkins	Chief Technology Officer	$1.8M			Sep 15, 2022
Ronald V. Swanson	Chief Scientific Officer	$1.8M			Sep 6, 2022
Gilla Kaplan	Director	$1.79M			Jun 13, 2024
Esther van den Boom	Chief Financial Officer	$1.58M			Sep 15, 2022
Hiroomi Tada	Chief Medical Officer	$569K			Mar 15, 2024
Piyush R. Patel	Chief Development Officer	$485K			Feb 21, 2023
Stephen Michael Rothenberg	Director	$464K			May 7, 2024
Susan Moran	Director	$464K			May 7, 2024
MVA Investors, LLC	10%+ Owner	$148K			Feb 9, 2023
Alan Fuhrman	Chief Financial Officer	$29.9K			Aug 14, 2024
Siddarth Subramony	Director, 10%+ Owner				May 29, 2024
Ali D. Fawaz	General Counsel and Secretary				May 16, 2022
Nina S. Kjellson	Director				May 29, 2024
Jake Simson	Director				May 29, 2024
Isan Chen	Director				May 31, 2023
Douglas J. Warner	Chief Medical Officer				Sep 9, 2024
Melissa McCracken	Director				Sep 14, 2021
Robert J. More	Director				May 29, 2024
John Stephen Healy	General Counsel and Secretary				Mar 1, 2022
Rehan Verjee	Director				May 29, 2024

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.